Silence Therapeutics plc files 424B5 for at-the-market offering of ADSs at $6.10 per share

Filed May 27, 2026 · ~1 min read

Key Changes

• high

  Silence Therapeutics plc is offering American Depositary Shares (ADSs) at $6.10 per share in an at-the-market offering, with no specified number of shares or total offering size disclosed.

  The Offering verify on EDGAR →
• high

  Investors will incur immediate substantial dilution of $3.98 per ADS based on the assumed offering price of $6.10 and pro forma net tangible book value as of March 31, 2026.

  Risk Factors verify on EDGAR →
• medium

  The ADSs may be sold in at-the-market offerings, meaning investors buying at different times will likely pay different prices.

  Risk Factors verify on EDGAR →